Related by context. All words. (Click for frequent words.) 67 diabetes mellitus 66 Insulin Resistance 66 Diabetic Patients 66 Newly Diagnosed 65 Diabetic Nephropathy 65 Chronic Heart Failure 65 Coronary Artery Disease 65 Pulmonary Arterial Hypertension 64 Non Alcoholic Fatty 64 Ischemic Stroke 64 Chronic Kidney Disease 64 diabetes mellitus T2DM 64 Prediabetes 64 Impaired Glucose Tolerance 64 Nonalcoholic Fatty Liver Disease 64 diabetes mellitus DM 64 T2DM 63 Cardiovascular Outcomes 63 Cardiovascular Risk 63 Dyslipidemia 63 Controlled Trial 63 Metabolic Syndrome 63 Hepatocellular Carcinoma 63 Chronic Hepatitis B 63 Acute Renal Failure 62 Overactive Bladder 62 Rheumatoid Arthritis RA 62 T1DM 62 Acute Coronary Syndrome 62 Chronic Myeloid Leukemia 62 Chronic Hepatitis C 62 Psychiatric Disorders 62 Chronic Constipation 62 Subgroup Analysis 62 Hypertension 62 Renal Cell Carcinoma 62 Secondary Hyperparathyroidism 62 Venous Thromboembolism 62 Treating Chronic 62 Prehypertension 62 Heart Failure 62 Cardiovascular Risk Factors 62 Sudden Cardiac Death 62 Hyperphosphatemia 61 Urinary Incontinence 61 Valvular Heart Disease 61 Neovascular Age Related Macular 61 Systemic Sclerosis 61 Meta Analysis 61 Diabetes mellitus 61 Invasive Breast Cancer 61 Pooled Analysis 61 Cardiovascular Events 61 Severe Asthma 61 Peripheral Artery Disease 61 Allergic Rhinitis 61 Surgical Treatment 61 Microalbuminuria 61 Acute Coronary Syndromes 61 diabetes 61 Relapsing Multiple Sclerosis 61 Diabetes 61 Thrombotic 61 Infarction 60 Acute Decompensated Heart Failure 60 Systemic Lupus Erythematosus 60 Non Insulin Dependent 60 Severe Sepsis 60 Congestive Heart Failure 60 Nephropathy 60 Diabetic Retinopathy 60 Chronic Renal Failure 60 Inflammatory Markers 60 ST Elevation Myocardial 60 Newly Diagnosed Multiple Myeloma 60 Advanced Renal Cell 60 Double Blind Placebo 60 Malignant Melanoma 60 Oral Fingolimod 60 Relapsed Refractory 60 Cognitive Impairment 60 Myelodysplastic Syndrome 60 Iron Overload 60 Prospective Randomized 60 impaired glucose tolerance 60 Clinical Efficacy 60 Hypercholesterolemia 60 Artery Disease 60 Glycemic Control 60 Liver Failure 60 Systemic Lupus Erythematosus SLE 60 SHPT 60 Intracerebral Hemorrhage 60 Chronic Bronchitis 60 Acute Myocardial Infarction 60 Thiazolidinediones 60 Heart Failure Patients 60 Acute Ischemic Stroke 60 Diabetic Neuropathy 60 Ischemic 60 Renal Disease 60 Randomized Controlled Trial 59 Myocardial Ischemia 59 Chronic Insomnia 59 Relapsing Remitting Multiple Sclerosis 59 Esophageal Cancer 59 Arterial Disease 59 Elderly Patients 59 Left Ventricular Dysfunction 59 Immune Mediated 59 Thromboembolism 59 ST Segment Elevation 59 Preterm Delivery 59 NIDDM 59 Combination Treatment 59 See CLINICAL PHARMACOLOGY 59 Heterozygous Familial Hypercholesterolemia 59 systolic hypertension 59 Postmenopausal Women 59 AA Amyloidosis 59 Previously Treated 59 IDDM 59 Advanced Melanoma 59 Myelodysplastic Syndromes 59 Diabetic Macular Edema 59 diabetes dyslipidemia 59 Major Depressive Disorder 59 Insulin Therapy 59 Solid Tumors 59 Dendritic Cells 59 lupus erythematosus 59 proliferator activated receptor 59 Short Stature 59 Complicated Skin 59 Hyperkalemia 59 Patients Receiving 59 Tiotropium 59 diabetic nephropathy 59 Hyperlipidemia 59 Carotid Stenting 59 Kidney Failure 59 Hypertensive 59 Systematic Review 59 Hepatitis C Virus 59 Peripheral Arterial Disease 59 Chronic Sinusitis 59 Impaired glucose tolerance 58 Hypertensive Patients 58 Randomized Double blind 58 Inflammatory Bowel Disease 58 Hemodialysis Patients 58 Chronic Lymphocytic Leukemia 58 Prolongs Survival 58 Investigational Treatment 58 Prophylactic Treatment 58 Resistant Hypertension 58 Neuroendocrine Tumors 58 Growth Hormone Deficiency 58 Myocardial Infarction 58 Atypical Hemolytic Uremic Syndrome 58 Hyperuricemia 58 Cognitive Deficits 58 Antihypertensive 58 Sleep Disordered Breathing 58 Skeletal Muscle 58 Polycystic Ovary Syndrome 58 Atherosclerotic 58 Multicenter Study 58 Autoimmune Disease 58 MPGN 58 Metastatic Prostate Cancer 58 Treatment Resistant 58 Colorectal Adenomas 58 Controlled Study 58 Gastric Cancer 58 Renal Function 58 Non Alcoholic Steatohepatitis 58 Cardiovascular Disease 58 Juvenile Idiopathic Arthritis 58 Patients Suffering 58 Bladder Cancer 58 Antitumor Activity 58 hyperlipidaemia 58 Coronary Artery Bypass Graft 58 Myelodysplastic Syndrome MDS 58 dyslipidaemia 58 Prevent Stroke 58 Multicenter Randomized 58 2 diabetes T2D 58 Investigational Drug 58 Soft Tissue Sarcoma 58 Naive Patients 58 Diabetic Complications 58 Proteinuria 58 Myelofibrosis 58 Diabetic Eye 58 Systolic Hypertension 58 Obstructive Sleep Apnea 58 Rheumatic Fever 58 Mitral Regurgitation 58 Comorbidities 58 Angina 58 nonalcoholic steatohepatitis NASH 58 Pulmonary Hypertension 58 Inhaled Liposomal Ciprofloxacin 58 arterial hypertension 58 Exacerbation 58 Infarct 58 Bipolar Mania 58 Cutaneous T 58 Peptic Ulcer 58 Chronic Inflammatory 57 Anticoagulation 57 atherogenic dyslipidemia 57 Insulin Glargine 57 Cardiovascular Mortality 57 Oral Cavity 57 Kidney Disease 57 Glycemia 57 Lupus Nephritis 57 Aggressive Reduction 57 Pediatric Patients 57 Critical Limb Ischemia CLI 57 Liver Disease 57 Paroxysmal Nocturnal Hemoglobinuria PNH 57 Renal Failure 57 primary hypercholesterolemia 57 Diabetic Foot Ulcers 57 Poorly Controlled 57 familial hypercholesterolemia 57 Genetic Variation 57 Antiviral Therapy 57 Cognitive Function 57 Arrhythmias 57 Nonalcoholic Steatohepatitis 57 Hypertriglyceridemia 57 Metastatic Melanoma 57 Clinical Trial Results 57 Improve Survival 57 Metastatic Colorectal Cancer 57 Mouse Model 57 Knee Osteoarthritis 57 Left Ventricular 57 microalbuminuria 57 Gaucher Disease 57 Eye Diseases 57 Castration Resistant Prostate Cancer 57 Slow Progression 57 Diabetes Complications 57 Acute Heart Failure 57 Cardiovascular Disease Risk 57 Progressive Multifocal Leukoencephalopathy 57 Increased Mortality 57 Laryngeal Cancer 57 Follicular Lymphoma 57 Bronchiectasis 57 Periodontal Disease 57 Sclerosis 57 Natalizumab 57 Multiple Myeloma Patients 57 Dual Antiplatelet Therapy 57 NAFLD 57 Hormone Refractory Prostate Cancer 57 Randomized Study 57 hypercholesterolemia 57 Clostridium difficile Infection 57 chronic HCV infection 57 hypertension 57 Thyroid Cancer 57 Atherosclerosis 57 Critically Ill Patients 57 Randomized Double Blind 57 Critical Limb Ischemia 57 Thromboembolic 57 Prospective Cohort Study 57 Generalized Anxiety Disorder GAD 57 Breast Cancer Recurrence 57 Insulin Sensitivity 57 Endothelial Function 57 Hypoparathyroidism 57 Crit Rev 57 Kidney Function 57 Valsartan 57 hyperphosphatemia 57 Statin Therapy 57 COPD 57 symptomatic BPH 57 systemic lupus erythematosus 57 Increased Risk 57 Ulcerative Colitis 57 Late Breaker 57 hyperphenylalaninemia HPA due 57 Blood Cancers 57 Chronic Conditions 57 Fracture Risk 56 Premature Infants 56 Parkinsonism 56 Aortic Stenosis 56 pulmonary hypertension PH 56 Panic Disorder 56 Leukemias 56 juvenile myoclonic epilepsy 56 Adjuvant Chemotherapy 56 Ranolazine 56 Coronary Arteries 56 Albuminuria 56 Prevalence Estimates 56 Diabetic Foot 56 Diabetes Epidemic 56 Acute Pancreatitis 56 Rheumatoid 56 Renal Anemia 56 Placebo Controlled Study 56 Radiofrequency Ablation 56 Benign Prostatic Hyperplasia 56 Hypoactive Sexual Desire Disorder 56 Multicenter Phase 56 Localized Prostate Cancer 56 Androgen Deprivation Therapy 56 Adult Onset 56 metabolic syndrome 56 Genetic Variant 56 lactic acidosis 56 Premenopausal Women 56 Alzheimers Disease 56 Phase 2b Clinical Trial 56 Unresectable 56 Philadelphia Chromosome Positive 56 Infected Patients 56 Bronchial Asthma 56 overt nephropathy 56 Pulmonary Arterial Hypertension PAH 56 Successfully Treated 56 Phase 2b Trial 56 diabetes mellitus NIDDM 56 Decompensated 56 Female Sexual Arousal 56 Primary Hypercholesterolemia 56 Irritable Bowel Syndrome 56 Prospective Multicenter 56 Tyrosine Kinase Inhibitor 56 Hemorrhagic Stroke 56 Peripheral Vascular Disease 56 Septic Shock 56 vWD 56 Blood Pressure Monitoring 56 Kidney Stones 56 Thyroid Hormone 56 Rheumatoid Arthritis 56 Cardiotoxicity 56 Thyroid Disease 56 Chronic Diseases 56 Evaluation WISE 56 Vascular Disease 56 Hemochromatosis 56 Treatment Naive Patients 56 Clinical Outcomes 56 Nonalcoholic fatty liver 56 elevated triglycerides 56 purpura ITP 56 Hepatic Encephalopathy 56 Ischaemic 56 Hemolysis 56 ACE Inhibitors 56 Asymptomatic 56 ACE Inhibitor 56 Venous Thrombosis 56 Respiratory Infections 56 Intracranial 56 Severe Primary IGFD 56 intermittent claudication 56 Depressive Symptoms 56 Schizoaffective Disorder 56 Chronic Rhinosinusitis 56 Menopausal Symptoms 56 Emerging Therapies 56 HeFH 56 Clinical Practice Guideline 56 Patient Outcomes 56 Rheumatoid Arthritis Patients 56 Sapacitabine 56 dyslipidemia 56 Leber Hereditary Optic Neuropathy 56 Ankylosing Spondylitis 56 Adenocarcinoma 56 Asthma COPD 56 Hip Fractures 56 Acute Exacerbations 56 Vitamin D Deficiency 56 Atrial Fibrillation 56 Chronic Kidney 56 Differential Diagnosis 56 Hospital Acquired Pneumonia 56 J Nutr 56 Plus Ribavirin 56 Liver Metastases 56 Disease Progression 56 serum phosphate 56 Chronic Pelvic Pain 56 Nocturia 56 Recurrent Stroke 56 Stable Coronary Artery 56 Insulin Secretion 56 Irritable Bowel Syndrome IBS 56 HCV Protease Inhibitor 56 Community Acquired Pneumonia 56 delta gamma agonist 56 Hematological 56 Paroxysmal Nocturnal Hemoglobinuria 56 Enzastaurin 56 Serious Infections 56 homozygous familial hypercholesterolemia 56 Hospitalized Patients 56 Percutaneous Coronary Intervention 56 Prematurity ROP 56 Renal Impairment 56 Neoplasms 56 hyperglycaemia 56 Lowers Risk 56 Multicenter Trial 56 Chronic Lymphocytic Leukemia CLL 56 Endometrial Cancer 56 AAT Deficiency 56 #-# Full Text 56 Antipsychotic 56 Advanced Prostate Cancer 56 1 diabetes T1D 56 Lung Function 55 PAOD 55 Arterial Hypertension 55 NYHA Class III 55 Ischemia 55 Anthracycline 55 Hypertrophy 55 Chronic Lung 55 Valvular 55 Brain Shrinkage 55 Exacerbations 55 Etiology 55 Coronary Artery 55 disease NAFLD 55 Colorectal Cancer Screening 55 Multiple Myeloma MM 55 PGTC seizures 55 Suicidality 55 Irritable Bowel 55 Predict Risk 55 Survival Benefit 55 pancreatic insufficiency 55 Gestational Diabetes 55 Antiretroviral Therapy 55 Chronic Cough 55 Sleep Disturbances 55 Severely Obese 55 Autoimmune Diseases 55 Hypogonadism 55 Carcinoma 55 Childhood Asthma 55 Study Evaluating 55 Diabetes Obesity 55 Subtypes 55 Hypoglycemia 55 Shows Promise Against 55 Delayed Graft Function 55 Aortic stenosis 55 Improve Outcomes 55 NOMID 55 Chronic HCV 55 Syncria R 55 Bipolar Depression 55 Fungal Infections 55 Inflammatory Diseases 55 Pioglitazone 55 familial amyloidotic polyneuropathy FAP 55 Beneficial Effects 55 Preeclampsia 55 Gene Mutation 55 Postherpetic Neuralgia 55 Acute Myelogenous Leukemia AML 55 Genetic Basis 55 Parkinson Disease PD 55 Genital Herpes 55 Breast Carcinoma 55 Malignant Glioma 55 Vulnerable Plaque 55 elevated LDL cholesterol 55 Gastric Ulcers 55 complement inhibitor eculizumab 55 Adrenal 55 Anaemia 55 Metabolic Disorder 55 Treatment Reduces 55 Unstable Angina 55 Hepatitis B Virus 55 Novel Treatments 55 Adenomas 55 ankylosing spondylitis AS 55 Erectile Dysfunction 55 Proves Effective 55 HIV HCV coinfected 55 Symptom Relief 55 Chronic lymphocytic leukemia 55 Therapeutic Effects 55 HoFH 55 Inflammatory Arthritis 55 Rectal Cancer 55 Coronary Artery Calcium 55 Pleural Mesothelioma 55 Advanced Pancreatic Cancer 55 Decompensated Heart Failure 55 Iron Deficiency 55 Hepatotoxicity 55 nonalcoholic steatohepatitis 55 Cardiac Biomarkers 55 AFib 55 dual PPAR peroxisome 55 Diabetic Foot Ulcer 55 Pharmacologic 55 Nicotine Addiction 55 Clinical Practice Guidelines 55 Pivotal Phase 55 Drug Prevents 55 Randomized Controlled Trials 55 Improved Survival 55 Metastases 55 ADHF 55 High Blood Pressure 55 Phase IIa Clinical Trial 55 Reduces Mortality 55 Stress Induced 55 chronic thromboembolic pulmonary 55 Prognostic Factors 55 Latex Allergy 55 Generalized Anxiety Disorder 55 Occlusive Disease 55 hypovitaminosis D 55 hypercholesterolaemia 55 Acute Myeloid Leukaemia AML 55 bacterial prostatitis 55 Advanced Ovarian Cancer 55 Ventricular Tachycardia 55 Cardiac Resynchronization 55 Stenosis 55 Beta Blocker 55 retinal vein occlusion 55 CABG Surgery 55 Insulin Delivery 55 Therapy Improves 55 dual endothelin receptor antagonist 55 Anemia 55 urolithiasis 55 Cerebril TM 55 Autoantibodies 55 Bipolar Disorders 55 Ischemic Heart Disease 55 Social Anxiety Disorder 55 Sexual Dysfunction 55 insulin resistance syndrome 55 Pafuramidine 55 Bipolar Disorder 55 Atopic Dermatitis 55 Long Term Outcomes 55 Hormone Replacement 55 FASEB J. 55 Stomach Cancer 55 Aggressive Behavior 55 Total Hip Replacement 55 Intervention Trial 55 Hormone Receptor Positive 55 Idiopathic 55 eosinophilic asthma 55 Anticoagulants 55 psoriatic arthritis PsA 55 Aneurysm Repair 55 Malignancies 55 Diabetes Hypertension 55 serum leptin 55 Improves Outcomes 55 Randomized Controlled 55 Enlarged Prostate 55 Postmenopausal Osteoporosis 55 Gastric Bypass Surgery 55 1 Diabetes TrialNet 55 Arteriosclerosis 55 Hypertrophic 55 nonalcoholic fatty liver 55 Relapsed Multiple Myeloma 55 Epileptic Seizures 55 Vertebral Fractures 54 ATACAND 54 Psychotic Disorders 54 Inflammatory Bowel Diseases 54 Bone Mineral Density 54 Peripheral arterial disease 54 Virus Infection 54 Lymphocytic 54 Clinical Outcome 54 Phase Ib Clinical Trial 54 Novel Mechanism 54 Cachexia 54 Circulatory 54 Progenitor Cells 54 C Reactive Protein 54 Pneumococcal Vaccine 54 dilated cardiomyopathy DCM 54 essential thrombocythemia 54 Renal Cancer 54 Preclinical Models 54 Bronchopulmonary Dysplasia 54 Cirrhosis 54 Neuroprotection 54 Allogeneic 54 Obstructive Sleep Apnoea 54 Antiplatelet 54 Pemphigus 54 Bone Fractures 54 Demonstrates Efficacy 54 Patients Undergoing 54 Squamous Cell Carcinoma 54 Neoplasia 54 Portal Hypertension 54 Renal Cell Carcinoma RCC 54 Gene Linked 54 Reduced Risk 54 immune idiopathic thrombocytopenic 54 Suicidal Ideation 54 Brentuximab Vedotin SGN 54 Non Inferiority 54 Systolic Blood Pressure 54 HCV Genotype 54 Nesiritide 54 Autologous Stem Cell Transplantation 54 Tolvaptan 54 chronic immune thrombocytopenic 54 Rhinosinusitis 54 hyperhomocysteinemia 54 Migraine Headache 54 Intracerebral 54 Idiopathic Pulmonary Fibrosis 54 Blood Glucose 54 tumor lysis syndrome 54 Neuroprotective Effects 54 oral antidiabetic medication 54 Enzyme Replacement Therapy 54 Gum Disease 54 Guidelines Issued 54 Coronary Heart Disease 54 2 diabetes UKPDS 54 systemic lupus erythematosus SLE 54 Periodontitis 54 Dental Caries 54 T Cell Lymphoma 54 Treating Heart Failure 54 Low Incidence 54 invasive candidiasis 54 Autoimmunity 54 Stem Cell Treatment 54 Unfractionated Heparin 54 von Willebrand disease 54 Heart Disease 54 Hyperglycemia 54 atherothrombosis 54 Novel Oral 54 Anti Tumor 54 peripheral arterial disease 54 Uric Acid 54 Arch Neurol 54 Slows Progression 54 Immunosuppression 54 Glucocorticoids 54 Lipid Metabolism 54 Orthostatic Hypotension 54 Orally Active 54 autoimmune thyroid 54 B Cell Lymphoma 54 Liver Cirrhosis 54 Free Full Text 54 triglyceride levels 54 overactive bladder syndrome 54 Ear Infections 54 Hematologic 54 Randomized Clinical Trial 54 Dialysis Patients 54 von Willebrand Disease 54 Adjunctive 54 acute coronary syndromes ACS 54 #:#-# [031] 54 ANN INTERN MED 54 Arrhythmogenic 54 Fibrosis 54 Liver Injury 54 proliferative diabetic retinopathy 54 Interstitial Cystitis 54 Etanercept 54 Nephrol Dial Transplant 54 Postnatal Depression 54 Endocrinol 54 Early Diagnosis 54 Polycystic ovary syndrome PCOS 54 macroalbuminuria 54 Beta Blockers 54 Retinal Vein Occlusion 54 Dilated Cardiomyopathy 54 Bone Metastases 54 LUX Lung 54 Iron Deficiency Anemia 54 NYHA Class II 54 Uterine Fibroid Embolization 54 Bulimia Nervosa 54 Allergic Asthma 54 Osteoporosis 54 atherothrombotic 54 Fabry Disease 54 Shows Efficacy 54 HCV SPRINT 54 Alcohol Consumption 54 cardiovascular disease CVD 54 Gene Variation 54 Adrenal Fatigue 54 Hepatitis C Genotype 54 Mortality Risk 54 Migraine Headaches 54 Osteoarthritis Patients 54 Lipodystrophy 54 Thrombus 54 Cholesterol Levels 54 Inhaled Corticosteroids 54 Stress Incontinence 54 Neoadjuvant Chemotherapy 54 Preterm Birth 54 HbA1c levels 54 Angioedema 54 acute humoral rejection 54 Peginterferon Alfa 2a 54 erythematosus 54 Pamidronate 54 Prenatal Diagnosis 54 Antipsychotic Medications 54 basal cell nevus syndrome 54 Gastroparesis 54 Radical Prostatectomy 54 LUMINATE 54 Autoimmune 54 gallstone disease 54 Often Misdiagnosed 54 Arch Intern Med 54 Oesophageal 54 Levels Linked 54 Bucindolol 54 Obesity Linked 54 diabetes hyperlipidemia 54 Juvenile Idiopathic Arthritis JIA 54 Genetic Disorders 54 Prostate Cancer Screening 54 Respiratory Distress 54 chronic kidney 54 Left Ventricular Hypertrophy 54 J Pediatr 54 NovoRapid 54 Brain Atrophy 54 Myoblast 54 Metabolic Disorders 54 HIV Infection 54 Oral Interferon 54 Chronic Myelogenous Leukemia 54 cell lymphoma CTCL 54 Benign Prostatic Hyperplasia BPH 54 preserved ejection fraction 54 polyarticular 54 Ozarelix 54 Randomized Trials 54 Dupuytren Contracture 54 rheumatoid arthritis osteoarthritis ankylosing 54 LHON 54 Suicidal Behavior 54 Potent Antiviral Activity 54 Parkinson disease PD 53 Visceral Fat 53 Cardiac Arrhythmias 53 Diabetic Neuropathic Pain 53 Double Blind Randomized 53 Bloodstream Infections 53 Breast Cancer Survival 53 lipid abnormalities 53 disease GERD 53 angina pectoris 53 Genes Predict 53 Novel Therapeutic 53 Hereditary angioedema HAE 53 Acute Coronary Syndromes ACS 53 Cardiac Function 53 mixed dyslipidemia 53 Chronic Prostatitis 53 Prophylaxis 53 Substance Use 53 Sjogren Syndrome 53 Heart Failure Trial 53 Vildagliptin 53 Immune Responses 53 Minimally Invasive Treatment 53 chronic eosinophilic leukemia 53 Mild Cognitive Impairment 53 Fecal Incontinence 53 Sinusitis 53 acute PAO 53 Prevent Heart 53 Ambulatory Blood Pressure 53 variceal bleeding 53 Hp2 2 53 Thrombolytic Therapy 53 malignant pleural mesothelioma 53 Cardiometabolic 53 Postmenopausal 53 Cardiometabolic Risk 53 Osteoporotic 53 Carotid Endarterectomy 53 invasive aspergillosis 53 Retinopathy 53 mixed hyperlipidemia 53 Social Phobia 53 Ramipril 53 Obese Patients 53 Vascular Inflammation 53 Endocarditis 53 MPS VI 53 Acute Treatment 53 chronic renal failure 53 Osteoporosis Treatment 53 Medication Adherence 53 Cerebrospinal Fluid 53 isolated systolic hypertension 53 FOLOTYN ® 53 Rheumatic Heart 53 alcoholic fatty liver 53 Phase III Clinical Trial 53 Gluten Intolerance 53 Pediatric Asthma 53 Appears Safe 53 Antiplatelet Therapy 53 Urinary Tract Infections 53 Blood Pressure Lowering 53 Demonstrates Sustained 53 Sickle Cell Anaemia 53 Treatment Options 53 Neurodegenerative 53 lipohypertrophy 53 Hepatitis C Infection 53 CIMZIA TM certolizumab pegol 53 Therapeutic Advances 53 Thrombocytopenia 53 Molecular Basis 53 J Clin Endocrinol Metab 53 painful diabetic neuropathy 53 hereditary antithrombin deficiency 53 open angle glaucoma 53 Keratitis 53 mild renal insufficiency 53 Sustained Reduction 53 Drug Shows Promise 53 Lipid Levels 53 Diabetic Peripheral Neuropathy 53 Plaque Psoriasis 53 Opioid Dependence 53 Randomized Phase II 53 progressive dyspnea 53 prediabetes 53 Breast Cancers 53 Sleep Disorder 53 atherothrombotic disease 53 Fatty Liver Disease 53 secondary hyperparathyroidism 53 Metastatic Renal Cell Carcinoma 53 colorectal cancer CRC 53 null responder HCV 53 Age Related Macular 53 acute coronary syndromes 53 Diuretic 53 Lung Cancer Survival 53 GH deficiency 53 Stroke Risk 53 ADPKD 53 Oxidative Stress 53 Atrial 53 extrapyramidal symptoms 53 Victoza R 53 smoldering multiple myeloma 53 Diabetic Kidney Disease 53 Genetic Marker 53 Fibromyalgia Syndrome 53 Environ Health Perspect 53 hepatorenal syndrome 53 Anticancer Activity 53 Chronic Liver Disease 53 Implantable Cardioverter Defibrillator 53 Effective Treatments 53 Mental Illnesses 53 Alzheimer Disease AD 53 chronic rheumatic 53 Uterine Fibroids 53 #:#-# [023] 53 Nilotinib 53 Diastolic Heart Failure 53 Chronic Obstructive Pulmonary 53 Genes Associated 53 ACER paper 53 riociguat 53 Arthritis Rheum 53 Phospholipase A2 53 BERKELEY CA UroToday.com 53 Immune Thrombocytopenic Purpura 53 endometrial hyperplasia 53 Hemophilia B 53 Artificial Pancreas 53 proteinuria 53 Esophagitis 53 coagulation abnormalities 53 Genetic Markers 53 treatment naive genotype 53 Stress Urinary Incontinence 53 recurrent glioma 53 J Cardiovasc 53 Gastric Ulcer 53 Peripheral Arterial 53 Peritoneal Dialysis 53 MADIT II 53 JAK2 Inhibitor 53 Phenotype 53 Eye Disease 53 Randomised Controlled Trial 53 Refractory Angina 53 Respiratory Syncytial Virus 53 Comorbid 53 Pregnancy Outcomes 53 ExTRACT TIMI 53 left ventricular hypertrophy 53 Metabolic Endocrinology 53 Acute Myelogenous Leukemia 53 Acute Liver Failure 53 STRIDE PD 53 Effectively Treats 53 simplex virus 53 cytomegalovirus infection 53 Acidosis 53 Late Onset 53 abdominal adiposity 53 Prolongs Life 53 LDL Cholesterol 53 Fondaparinux 53 Pancreatitis 53 erythematosus SLE 53 Blood Pressure 53 renal insufficiency 53 rare autosomal recessive 53 Esophageal 53 Acute Promyelocytic Leukemia 53 Sulfonylurea 53 Therapeutic Targets 53 Dialysis Outcomes 53 post thrombotic syndrome 53 Genetic Variations 53 Aggressive Prostate Cancer 53 Osteoarthritis Pain 53 Subarachnoid hemorrhage 53 Liver Cancer 53 Primary Immune Deficiency 53 diabetic retinopathy 53 thiazolidinedione TZD 53 thyrotoxicosis 53 systemic juvenile idiopathic 53 Skin Disease 53 Low Testosterone 53 Hyponatremia 53 Yeast Infections 53 Abdominal Fat 53 progressive neurodegenerative disorder 53 Antithrombotic 53 Morquio 53 Estrogen Therapy 53 Coronary Disease 53 myelofibrosis polycythemia vera 53 candidemia 53 comorbid depression 53 Malignant Mesothelioma 53 Colorectal Cancers 53 Renal dysfunction 53 Risk Stratification 53 Neovascularization 53 proliferative retinopathy 53 Lubiprostone 53 Gastrointestinal Disorders 53 Glatiramer Acetate 53 Diabetes Digestive 53 atrophic gastritis 53 Psoriatic arthritis 53 metastatic colorectal carcinoma 53 Predict Response 53 severe obstructive pulmonary 53 J Clin 53 Congenital Heart Disease